GE HealthCare Technologies’ (GEHC) Buy Rating Reaffirmed at BTIG Research

BTIG Research reiterated their buy rating on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research report released on Thursday,Benzinga reports. BTIG Research currently has a $91.00 price target on the stock.

GEHC has been the subject of several other reports. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 4th. Barclays increased their price target on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Friday, February 6th. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Finally, Piper Sandler raised their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, January 30th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $70.38 on Thursday. The firm has a market capitalization of $32.08 billion, a P/E ratio of 15.43, a P/E/G ratio of 1.54 and a beta of 1.03. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The stock’s 50-day simple moving average is $79.57 and its two-hundred day simple moving average is $78.41. GE HealthCare Technologies has a twelve month low of $57.65 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter last year, the company posted $1.45 EPS. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is presently 3.07%.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds have recently bought and sold shares of the business. Wedge Capital Management L L P NC bought a new stake in GE HealthCare Technologies during the third quarter valued at approximately $26,859,000. Valicenti Advisory Services Inc. grew its stake in shares of GE HealthCare Technologies by 22.6% in the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after buying an additional 12,550 shares in the last quarter. Temasek Holdings Private Ltd bought a new position in GE HealthCare Technologies during the 3rd quarter valued at about $99,922,000. Locust Wood Capital Advisers LLC lifted its stake in GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after purchasing an additional 137,992 shares during the last quarter. Finally, Nan Fung Trinity HK Ltd. purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $23,206,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.